MMRF PRESS RELEASES
Multiple Myeloma Research Foundation (MMRF) Receives Highest Rating from Charity Navigator for Exceptional Fiscal Management
MMRF Honored for Seventh Year for Outstanding Stewardship of Donors? Funds
Norwalk, Connecticut — February 17, 2010
The Multiple Myeloma Research Foundation (MMRF) announced today that it has received a 4-star rating from Charity Navigator, America's largest independent evaluator of charitable donations, for demonstrating exceptional fiscal responsibility in its efforts to bring patients the next generation of treatments and find a cure for multiple myeloma. This is the seventh consecutive year the MMRF has been honored with this distinguished recognition.
The coveted 4-star rating, the highest honor Charity Navigator bestows, has been awarded to only two percent of charities. According to Charity Navigator, “this exceptional designation differentiates the MMRF from its peers and demonstrates to the public it is worthy of their trust.”
"Charity Navigator’s 4-star rating underscores our tireless commitment to accountability and measurable results” said Kathy Giusti, Founder and CEO of the MMRF. “Running lean and being efficient is an essential part of our culture. In today’s uncertain economy, it is more important to us than ever that our donors are certain we maximize every dollar they invest.”
In addition to receiving the 4-star rating from Charity Navigator, the MMRF has received A "Best in America" Seal of Excellence from the Independent Charities of America, an A+ from the American Institute of Philanthropy, and is in compliance with all of the Better Business Bureau's (BBB) Wise Giving Alliance Standards for Charity Accountability. The MMRF has also received approval from the National Cancer Institute for its research grants program.
About Multiple Myeloma
Multiple myeloma is an incurable blood cancer. The five-year relative survival rate for multiple myeloma is approximately 34 percent, one of the lowest of all cancers. In 2009, approximately 20,000 adults in the United States were diagnosed with multiple myeloma and approximately 11,000 people died from the disease.
About the Multiple Myeloma Research Foundation (MMRF)
The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)3 non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy's diagnosis with multiple myeloma. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. As the world's number-one private funder of multiple myeloma research, the MMRF has raised over $130 million since its inception to fund nearly 120 laboratories worldwide. An outstanding 93% of funds raised go toward research and related programming. The MMRF has supported 40 new compounds and approaches in clinical trials and pre-clinical studies and has facilitated 22 clinical trials through its sister organization, the Multiple Myeloma Research Consortium (MMRC). For more information about the MMRF, please visit www.themmrf.org.
Media Contact: Terri Clevenger, 203-227-0209, email@example.com